An interventional study of auricular laser acupuncture and sham auricular laser acupuncture in Breast Cancer Females and Insomnia, sponsored by CHING-RONG HUANG. Recruiting at 1 site in Taiwan. Open to female participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-10-07.
Sponsored by CHING-RONG HUANG · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 125 studies in Sleep Initiation and Maintenance Disorders with a site in Taiwan — 36 open to participants now, 38 under way, none of them phase 3. Sleep Initiation and Maintenance Disorders · Taiwan.
Among the 125 studies in Sleep Initiation and Maintenance Disorders with a site in Taiwan, this one is the 66th largest by planned enrollment of the 118 interventional ones that give a count, is one of 17 that started in 2026, is one of 113 with no phase, reaches primary completion later than 22 of the 37 other live ones, and was the 99th registered.
2,738 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 735 are open to participants now.
Browse Sleep Initiation and Maintenance Disorders studies →36 of the 125 studies in Sleep Initiation and Maintenance Disorders with a site in Taiwan are open now. Recruiting first, the newest first:
Taipei Medical University · Sites in Taiwan
Ages 65+
National Sun Yat-sen University · Sites in Taiwan
Ages 20–80
Tzu Chi University · Sites in Taiwan
Ages 30–75
Tzu Chi University · Sites in Taiwan
Ages 18–75
National Health Research Institutes, Taiwan · Sites in Taiwan
Ages 55+ · Healthy volunteers
A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →
Of the 394 Sleep Initiation and Maintenance Disorders studies recruiting now, 156 (40%) set no upper age limit and 208 (53%) stop at 75 or younger; 61 take children under 18; 112 take healthy volunteers.
This study: 18 Years to 75 Years · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
125 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 17 started in 2026.
This study's planned enrollment of 70 is close to the median of 68 across 2,363 interventional studies indexed under Sleep Initiation and Maintenance Disorders.
Median enrollment 76 across the 118 interventional studies, 130 across the 7 observational. Of the 66 that completed or were terminated, 4 (6%) have results posted.
This tab as a report to print or save as PDF → With an account.
5 of 125 have an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with CHING-RONG HUANG as lead sponsor.
CHING-RONG HUANG has 1 study filed under Sleep Initiation and Maintenance Disorders — fewer than ten, so there is no comparison to draw.
18 of the studies in Sleep Initiation and Maintenance Disorders with a site in Taiwan that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07603687National Taiwan University HospitalBrief Behavioral Intervention for Insomnia Among Adults With Sleep Disturbances | 2026-12 |
| NCT05402761Taipei Medical UniversityEffects of Nurse-Guided BBTi for Improving Insomnia : in Patients at the Recovery Following Traumatic Brain Injury | 2026-12 |
| NCT06854497Chiayi Christian HospitalThe Impact of Non-motor Symptom on the Outcome of Stroke Subjects | 2026-12-31 |
| NCT07114302Taipei Medical UniversityDigitally-Assisted Brief Behavioral Treatment for Insomnia in College Students | 2026-12-31 |
| NCT07027176Yea-Ru YangEffects of Walking Exercise on Sleep Quality in Older Adults | 2026-12-31 |
Add all 18 to your calendar (.ics) → With an account.
Among the 125 studies in Sleep Initiation and Maintenance Disorders with a site in Taiwan, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to learn if auricular laser acupuncture can improve sleep quality and alleviate related symptoms in female breast cancer patients aged 18 to 75 with insomnia. The main questions it aims to answer are:
Researchers will compare an active auricular laser acupuncture group to a sham control group (receiving no therapeutic laser energy) to see if active laser acupuncture is effective for symptom relief.
Participants will:
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The diagnosis was confirmed by looking at a sample under a microscope: tissue from a biopsy or surgery (histology), or cells from a fluid or needle sample (cytology).
Your pathology report is the document that shows this.
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
Histologically or cytologically confirmed
The diagnosis was confirmed by looking at a sample under a microscope: tissue from a biopsy or surgery (histology), or cells from a fluid or needle sample (cytology).
Your pathology report is the document that shows this.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
DSM diagnostic criteria
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Immunosuppression
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Device: auricular laser acupuncture
Device: sham auricular laser acupuncture
Using laser pen to stimulation ear acupoint at Shenmen, Subcortex, Heart, Kidney, Occiput, and Sympathetic points, administered for 15 minutes per session, twice weekly, for 5 weeks (10 sessions)
Using laser pen WITH NO LASER OUTPUT to stimulation ear acupoint at Shenmen, Subcortex, Heart, Kidney, Occiput, and Sympathetic points, administered for 15 minutes per session, twice weekly, for 5 weeks (10 sessions)
Pittsburgh Sleep Quality Index (PSQI)
Total scores range from 0 to 21. Higher scores indicate a worse outcome (poorer sleep quality).
Time frame: base line, 5 weeks (after treatment session)
Pittsburgh Sleep Quality Index (PSQI)
Total scores range from 0 to 21. Higher scores indicate a worse outcome (poorer sleep quality).
Time frame: baseline, 10 weeks (follow up)
Objective Sleep Efficiency Assessed by Actigraph
Objective parameters are recorded via wrist-worn ActiGraph monitor over 7 continuous days (5 weekdays, 2 weekends) per assessment to calculate daily averages. Metrics include: 1. Sleep Efficiency: Ratio of Total Sleep Time to Time in Bed (range: 0-100%). Higher values indicate a better outcome. 2. Total Sleep Time: Measured in minutes. Higher values indicate a better outcome. 3. Sleep Latency: Measured in minutes. Lower values indicate a better outcome. 4. Wake After Sleep Onset (WASO): Measured in minutes. Lower values indicate a better outcome. 5. Number of Awakenings: Count per period. Lower values indicate a better outcome. 6. Average Awakening Duration: Measured in minutes. Lower values indicate a better outcome.
Time frame: baseline, 5 weeks (after treatment session)
Subjective Sleep Quality Assessed by Sleep Diary
Subjective sleep parameters are recorded via daily sleep diary over 7 continuous days (5 weekdays, 2 weekends) per assessment to calculate daily averages. Metrics include: 1. Subjective Sleep Quality: Self-rated 5-point scale (range: 1-5; 1=Very Poor, 5=Very Good). Higher scores indicate a better outcome. 2. Total Sleep Time: Measured in minutes. Higher values indicate a better outcome. 3. Sleep Latency: Measured in minutes. Lower values indicate a better outcome. 4. Number of Awakenings: Count per night. Lower values indicate a better outcome. 5. Night Awakening Duration: Measured in minutes. Lower values indicate a better outcome.
Time frame: baseline, 5 weeks (after treatment session)
Autonomic Nervous System Function Assessed by Short-Term Heart Rate Variability (HRV)
Short-term (5-minute) resting HRV is measured to evaluate autonomic nervous system function. The metrics extracted for analysis include: 1. SDNN (Standard Deviation of NN intervals): Measured in milliseconds (ms). Higher values indicate a better outcome. 2. Total Power (TP): Measured in ms². Higher values indicate a better outcome. 3. HF (High Frequency power): Reflects parasympathetic activity, measured in ms². Higher values indicate a better outcome. 4. LF/HF Ratio: Calculated as the ratio of Low Frequency to High Frequency power. Lower values indicate a better outcome (reduced sympathetic hyperarousal).
Time frame: baseline, 5 weeks (after treatment session)
Functional Assessment of Cancer Therapy - Breast (FACT-B)
Total scores range from 0 to 148. Higher scores indicate a better outcome (better health-related quality of life).
Time frame: baseline, 5 weeks (after treatment session), 10 weeks (follow up)
Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-Fatigue)
Total scores range from 0 to 52. Higher scores indicate a better outcome (less fatigue).
Time frame: baseline, 5 weeks (after treatment session), 10 weeks (follow up)
Generalized Anxiety Disorder-7 (GAD-7)
Total scores range from 0 to 21. Higher scores indicate a worse outcome (greater severity of anxiety).
Time frame: baseline, 5 weeks (after treatment session), 10 weeks (follow up)
Patient Health Questionnaire-9 (PHQ-9)
Total scores range from 0 to 27. Higher scores indicate a worse outcome (greater severity of depression).
Time frame: baseline, 5 weeks (after treatment session), 10 weeks (follow up)
Plan to share: Undecided
No publications or documents are linked to this record.
Started Aug 2026 (actual). Primary completion is estimated for Jun 2027, 10 months after the start.
Of 1,219 non-industry interventional studies with no phase under Sleep Initiation and Maintenance Disorders, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 35. This study's planned 10 months is below that.
Counting every sponsor, half of 1,297 studies reached it within 15 months; a quarter within 6 and three quarters within 34.
Start moved once since we started tracking on Sep 25, 2026: Apr 2026 → Aug 2026, on Oct 7, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sleep Initiation and Maintenance Disorders →